medicines


HIV patients urge caution on EU FTA talks
People afflicted with the Aids virus have called on the government to proceed carefully on free-trade negotiations with the European Union, as the latter's demands for copyright protection could make it difficult for patients to access cheap medicines.
Trade deal to curb generic-drug use
Some countries whose governments purchase drugs with a set budget are also alarmed by signs that the TPP may grant new negotiating powers to the industry.
Pharma exports: India asks Japan to remove non-tariff barriers
India has asked Japan to remove all non-tax barriers to help the domestic industry take advantage of the comprehensive free-trade agreement and increase share in the Japanese market.
18 Thai civil society groups urge EU Parliament delegation to reconsider TRIPS-plus provisions in EU-Thailand FTA
The letter warns that the TRIPS-Plus provisions in the trade agreement between EU and Thailand – including border measures, data exclusivity, patent term extensions, and protection for new indications – would block access to generic medicines.
The Pacific free trade deal that's anything but free
Just Foreign Policy is offering a reward, now up to $21,100, to WikiLeaks if it publishes a draft copy of the TPP. People could add to the reward fund, or if in a position to do so, make a copy of the draft agreement available to the world.
Malaysia says no to TPP
Malaysian Health Minister Datuk Seri Liow Tiong Lai said the Trans-Pacific Partnership Agreement, which is being negotiated among eleven countries including the US and Malaysia, would be detrimental to the local medical industry.
Protesters: Free trade deals, drug patents derail AIDS fight
As the nineteenth International AIDS Conference continued in Washington Tuesday, thousands of protesters marched on the White House calling for an end to free trade deals that protesters argue make vital AIDS medicines unaffordable.
Access to medicines and intellectual property in Jordan
Delayed market entry of generics due to enhanced intellectual property protection cost Jordanian private consumers approximately 18 million US dollars annually
Mulroney wades into EU free-trade talks, egging on pharma
Former Canadian Prime Minister Brian Mulroney is wading into the high-stakes debate over patent protection in the free trade talks with Europe, and he's clearly taking sides.
Provinces join forces to keep EU free-trade deal from upping drug costs
The provincial premiers have undertaken a letter-writing campaign to demand compensation from the federal government for any increase in drug costs that might results from a free-trade agreement with Europe.